<?xml-stylesheet type='text/xsl' href='rsspretty.xsl' version='1.0'?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <atom:link href="http://www.law360.com/company_articles/1095" rel="self" type="application/rss+xml"/>
    <title>Law360: Davis Graham &amp; Stubbs </title>
    <link>http://www.law360.com/</link>
    <description>Latest articles for organization: Davis Graham &amp; Stubbs </description>
    <copyright>Copyright 2009 Portfolio Media, Inc.</copyright>
    <language>en-US</language>
    <image>
      <url>http://www.law360.com/images/headings/logo.gif</url>
      <title>Law360</title>
      <link>http://www.law360.com/</link>
    </image>
    <item>
      <title>BP, Others Try To Escape Drug Test Antitrust Action</title>
      <link>http://www.law360.com/articles/134923</link>
      <description>BP America Inc., ConocoPhillips Co., Shell Exploration &amp; Production Co. and other energy companies have told a federal judge that there is no reason for them to be targeted in a putative class action brought by employment drug screening firms alleging that DrugTest Inc. snuffed out competition for oil and gas industry clients.</description>
      <guid>http://www.law360.com/articles/134923</guid>
    </item>
    <item>
      <title>Wyeth, Schwarz Off Hook In Generic Reglan Suit</title>
      <link>http://www.law360.com/articles/134463</link>
      <description>Wyeth Inc. and Schwarz Pharma Inc. have prevailed again in a lawsuit that alleged the brand-name pharmaceutical companies should have warned consumers that a copycat version of their anti-heartburn medicine Reglan could cause an incurable neurological disorder.</description>
      <guid>http://www.law360.com/articles/134463</guid>
    </item>
    <item>
      <title>Q&amp;A With Holland &amp; Hart's Stephen Masciocchi</title>
      <link>http://www.law360.com/articles/122744</link>
      <description>The time it takes for the average appeal to be resolved can be frustrating for clients and marks a problem with the appeal system in the U.S., says Stephen G. Masciocchi, chair of Holland &amp; Hart LLP's appellate practice group.
</description>
      <guid>http://www.law360.com/articles/122744</guid>
    </item>
    <item>
      <title>US Fights Nu-West Bid For $10M Over Cleanup</title>
      <link>http://www.law360.com/articles/132347</link>
      <description>In a suit brought by Nu-West Industries Inc. over the federal government's alleged &#8220;incompetence&#8221; in its oversight of the mining company's efforts to clean up four historic phosphate mines in Idaho, the U.S. has denied that it should be required to hand over $10 million in relation to the cleanup. 
</description>
      <guid>http://www.law360.com/articles/132347</guid>
    </item>
    <item>
      <title>Generics Failure-To-Warn Case Enters Oral Arguments </title>
      <link>http://www.law360.com/articles/128868</link>
      <description>The U.S. Court of Appeals for the Eighth Circuit is set to hear oral arguments Tuesday in a case that will decide whether failure-to-warn product liability claims against generic-drug manufacturers are preempted by federal law.</description>
      <guid>http://www.law360.com/articles/128868</guid>
    </item>
    <item>
      <title>Pan American Silver To Buy Aquiline In $605M Deal</title>
      <link>http://www.law360.com/articles/128385</link>
      <description>Pan American Silver Corp. has plans to buy Aquiline Resources Inc. in a CA$626 million ($605 million) deal for the South American silver and gold mining company's stock and convertible securities.</description>
      <guid>http://www.law360.com/articles/128385</guid>
    </item>
    <item>
      <title>Shire Settles Generic Adderall Spat With Sandoz</title>
      <link>http://www.law360.com/articles/128064</link>
      <description>Irish drugmaker Shire PLC said Tuesday it had settled patent litigation over Sandoz Inc.'s abbreviated new drug application to market a generic version of Shire's attention deficit hyperactivity disorder drug Adderall XR.</description>
      <guid>http://www.law360.com/articles/128064</guid>
    </item>
    <item>
      <title>Nu-West Wants US To Pay $10M For Mine Cleanup</title>
      <link>http://www.law360.com/articles/120403</link>
      <description>Nu-West Industries Inc. has called the U.S. government &#8220;incompetent&#8221; in its oversight of the Idaho mining company's efforts to clean up four historic phosphate mines, and is seeking to recoup more than $10 million it's already spent on the job.</description>
      <guid>http://www.law360.com/articles/120403</guid>
    </item>
    <item>
      <title>Husch Blackwell Adds Securities, M&amp;A Partner</title>
      <link>http://www.law360.com/articles/107580</link>
      <description>Robert Attai, formerly a partner at Otten Johnson Robinson Neff &amp; Ragonetti PC, has joined the Denver office of Husch Blackwell Sanders LLP as a partner in the securities and mergers and acquisitions department.</description>
      <guid>http://www.law360.com/articles/107580</guid>
    </item>
    <item>
      <title>Dish Wins Reversal On DirecTV Noncompete Contract</title>
      <link>http://www.law360.com/articles/108735</link>
      <description>A Colorado appeals court has reversed a lower court decision and granted Dish Network Corp. an injunction preventing a former manager from going to work for rival The DirecTV Group Inc., in a decision that clarifies the meaning of &#8220;management personnel&#8221; under Colorado law.
</description>
      <guid>http://www.law360.com/articles/108735</guid>
    </item>
    <item>
      <title>Doctor's Testimony In Own Baycol Suit 'Inadmissible'</title>
      <link>http://www.law360.com/articles/106992</link>
      <description>An appeals court has upheld the dismissal of product liability claims by an elderly doctor who partly relied on his own expert testimony to prove that he was injured by Bayer Corp.'s cholesterol-lowering drug Baycol, agreeing with a lower court that the testimony was inadmissible.</description>
      <guid>http://www.law360.com/articles/106992</guid>
    </item>
    <item>
      <title>Fraud On Market Theory No Good In Ins. Case: Court</title>
      <link>http://www.law360.com/articles/99065</link>
      <description>The Colorado Supreme Court has held that a fraud on the market theory &#8212; typically invoked in securities class actions &#8212; can't be applied to maintain an insurance class action under a state consumer protection law, and that a trial court didn't abuse its discretion when it decertified the class in the case. </description>
      <guid>http://www.law360.com/articles/99065</guid>
    </item>
    <item>
      <title>Move For Interlocutory Appeal Denied In Reglan Case</title>
      <link>http://www.law360.com/articles/96640</link>
      <description>Generics makers including Teva Pharmaceuticals USA Inc. and Barr Pharmaceuticals LLC have lost their bid for an interlocutory appeal of a ruling denying their motions for summary judgment in a failure-to-warn suit over generic versions of Wyeth Inc.'s heartburn drug Reglan, arguing unsuccessfully that the claims in the suit are preempted by federal law.</description>
      <guid>http://www.law360.com/articles/96640</guid>
    </item>
    <item>
      <title>Fed. Circ. Takes On Prior Claim Construction Issue</title>
      <link>http://www.law360.com/articles/88145</link>
      <description>A federal appeals court has agreed to hear an interlocutory appeal of Shire LLC&#8217;s patent infringement case against Sandoz Inc. over hyperactivity disorder drug Adderall XR that raises a question of whether a patentee is precluded from relitigating claim construction issues determined in a previous case.</description>
      <guid>http://www.law360.com/articles/88145</guid>
    </item>
    <item>
      <title>Conte V. Wyeth Spotlights 'Pioneer Liability' Claims</title>
      <link>http://www.law360.com/articles/84238</link>
      <description>A lawsuit accusing Wyeth Inc. of failing to warn that a generic equivalent of its anti-heartburn medicine Reglan could cause an incurable muscular disorder could expose manufacturers to increased liability if the boundaries of &#8220;pioneer liability&#8221; claims continue to expand, lawyers following the case say.</description>
      <guid>http://www.law360.com/articles/84238</guid>
    </item>
    <item>
      <title>Judge Tosses Oil Antitrust Suits On Political Grounds</title>
      <link>http://www.law360.com/articles/82774</link>
      <description>A federal judge has dismissed a consolidated class action and two other suits that accused Citgo Petroleum Corp. of furthering the anti-competitive practices of oil-producing countries, concluding that the allegations hinged on political issues that remain beyond the realm of the courts. </description>
      <guid>http://www.law360.com/articles/82774</guid>
    </item>
    <item>
      <title>Wyeth Can Be Liable For Generic Warnings: Court</title>
      <link>http://www.law360.com/articles/76236</link>
      <description>A California appellate court has said makers of brand-name drugs can be held responsible for failing to warn of side effects suffered by those taking the generic equivalents of their medications.</description>
      <guid>http://www.law360.com/articles/76236</guid>
    </item>
    <item>
      <title>State Failure-To-Warn Claims Found Preempted</title>
      <link>http://www.law360.com/articles/74258</link>
      <description>A federal judge has dismissed failure-to-warn claims against several generic-drug makers &#8212; including Teva Pharmaceuticals USA Inc. and Barr Pharmaceuticals Inc. &#8212; over a heartburn medication, ruling that the U.S. Drug Price Competition and Patent Term Act preempts the state law claims.</description>
      <guid>http://www.law360.com/articles/74258</guid>
    </item>
    <item>
      <title>Shire's Adderall Patent Suit To Go On</title>
      <link>http://www.law360.com/articles/70477</link>
      <description>A federal judge has kept alive Shire LLC's patent infringement allegations against Sandoz Inc. over attention-deficit hyperactivity disorder drug Adderall XR, finding that questions still remain about whether Sandoz's proposed generic falls within the claims of Shire's patents.</description>
      <guid>http://www.law360.com/articles/70477</guid>
    </item>
    <item>
      <title>State High Court Declines Williams' Royalties Case </title>
      <link>http://www.law360.com/articles/34618</link>
      <description>The Colorado Supreme Court has decided not to review an appeal by The Williams Co., upholding a jury's $4 million award to a rancher who claimed the natural gas giant owed him royalties. </description>
      <guid>http://www.law360.com/articles/34618</guid>
    </item>
  </channel>
</rss>
